UPDATED Mar 17, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | kr1.42 | -4.7% | 2.0% | kr384.5m | kr1.80 | PS5.3x | E137.8% | n/a | Tech | ||
TFBANK | kr159.00 | -4.9% | 17.8% | kr3.4b | kr197.33 | PB1.6x | E22.9% | n/a | Banks | ||
ENRAD | kr4.04 | -2.9% | 6.3% | kr98.6m | kr5.00 | PE1700.4x | E62.0% | n/a | Capital Goods | ||
KAN | kr1.92 | 3.8% | -43.9% | kr156.5m | kr5.00 | PB3.3x | E131.9% | n/a | Pharmaceuticals & Biotech | ||
CINIS | kr34.20 | -1.2% | -28.2% | kr2.5b | kr75.00 | PB6.1x | E77.3% | n/a | Materials | ||
CHECK | kr36.50 | 8.3% | -8.0% | kr1.1b | kr64.50 | PE308.6x | E97.4% | n/a | Software | ||
DIGN | kr1.78 | -7.1% | -63.8% | kr125.1m | kr9.50 | PS1.5x | E139.0% | n/a | Healthcare | ||
SPAGO | kr0.30 | -2.9% | -61.0% | kr67.4m | kr1.48 | PS11.4x | E48.9% | n/a | Pharmaceuticals & Biotech | ||
HEXI | kr0.49 | 3.9% | -57.8% | kr177.7m | n/a | PS5.1x | E118.5% | n/a | Capital Goods | ||
DVYSR | kr94.00 | 4.2% | 25.3% | kr1.5b | kr115.39 | PS9x | E99.3% | n/a | Pharmaceuticals & Biotech | ||
SKOLON | kr21.90 | 1.9% | -10.6% | kr581.3m | kr27.50 | PE75.7x | E58.9% | 2.6% | Software | ||
W5 | kr82.00 | -10.6% | 16.8% | kr1.2b | kr110.00 | PS3.1x | E66.6% | n/a | Capital Goods | ||
XBRANE | kr1.15 | 43.5% | -98.6% | kr34.2m | kr61.38 | PB0.2x | E126.0% | n/a | Pharmaceuticals & Biotech | ||
BINV | kr16.86 | 0.2% | -36.7% | kr1.1b | kr108.50 | PS15.5x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
EGTX | kr6.45 | -0.8% | 29.6% | kr1.9b | kr13.13 | PS32.8x | E87.5% | n/a | Pharmaceuticals & Biotech | ||
TOURN | kr9.66 | 0% | -43.6% | kr94.2m | kr16.50 | PB2.8x | E117.5% | n/a | Media | ||
BIOVIC B | kr2.18 | -7.0% | -75.8% | kr183.2m | kr18.00 | PS25.2x | E82.5% | n/a | Pharmaceuticals & Biotech | ||
PAX | kr34.00 | -1.7% | -1.2% | kr646.4m | kr80.00 | PE78.5x | E63.3% | n/a | Healthcare | ||
INCOAX | kr1.78 | -5.3% | -9.9% | kr192.0m | kr3.04 | PS2.4x | E77.4% | n/a | Tech | ||
CRAD B | kr42.60 | 3.5% | 34.6% | kr1.4b | kr58.00 | PE31.1x | E30.0% | n/a | Healthcare | ||
PCELL | kr29.83 | -7.7% | -74.7% | kr1.6b | kr49.00 | PS5x | E71.7% | n/a | Capital Goods | ||
WAYS | kr19.52 | -5.2% | -74.1% | kr157.5m | kr45.00 | PS1.4x | E79.3% | 0% | Tech | ||
ACROUD | kr0.90 | -4.7% | -44.6% | kr155.4m | kr2.35 | PB5.8x | E132.8% | n/a | Consumer Services | ||
ORGC | kr2.65 | -8.6% | -24.5% | kr259.6m | kr3.00 | PS1.8x | E94.3% | n/a | Materials |